BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15213094)

  • 1. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.
    Halupa A; Bailey ML; Huang K; Iscove NN; Levy DE; Barber DL
    Blood; 2005 Jan; 105(2):552-61. PubMed ID: 15213094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis.
    Guihard S; Clay D; Cocault L; Saulnier N; Opolon P; Souyri M; Pagès G; Pouysségur J; Porteu F; Gaudry M
    Blood; 2010 May; 115(18):3686-94. PubMed ID: 20223923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.
    Miller CP; Heilman DW; Wojchowski DM
    Blood; 2002 Feb; 99(3):898-904. PubMed ID: 11806992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts.
    Socolovsky M; Nam H; Fleming MD; Haase VH; Brugnara C; Lodish HF
    Blood; 2001 Dec; 98(12):3261-73. PubMed ID: 11719363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
    Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
    Haq R; Halupa A; Beattie BK; Mason JM; Zanke BW; Barber DL
    J Biol Chem; 2002 May; 277(19):17359-66. PubMed ID: 11875080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J; Yuan B; Hu W; Lodish H
    Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).
    Bao H; Jacobs-Helber SM; Lawson AE; Penta K; Wickrema A; Sawyer ST
    Blood; 1999 Jun; 93(11):3757-73. PubMed ID: 10339482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.
    Slavova-Azmanova NS; Kucera N; Satiaputra J; Stone L; Magno A; Maxwell MJ; Quilici C; Erber W; Klinken SP; Hibbs ML; Ingley E
    Blood; 2013 Jul; 122(2):262-71. PubMed ID: 23692855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
    Kapur R; Zhang L
    J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
    Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL
    J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
    Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells.
    Penta K; Sawyer ST
    J Biol Chem; 1995 Dec; 270(52):31282-7. PubMed ID: 8537396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
    Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
    Myklebust JH; Blomhoff HK; Rusten LS; Stokke T; Smeland EB
    Exp Hematol; 2002 Sep; 30(9):990-1000. PubMed ID: 12225790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
    Sui X; Krantz SB; You M; Zhao Z
    Blood; 1998 Aug; 92(4):1142-9. PubMed ID: 9694701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.